News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-02-27 7:31:33 am MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor GlobeNewsWire
2024-02-22 7:30:0 am MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer GlobeNewswire
2024-02-07 5:1:0 am MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer Business Wire
2024-01-24 4:15:0 am MAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compounds Business Wire
2024-01-18 10:6:0 am MAIA Soars 20% on Interim Results From Lung Cancer Study Zacks
2024-01-17 6:0:0 am MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024 Business Wire
2024-01-05 5:0:0 am MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024 Business Wire
2023-12-19 4:0:0 am MAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer Business Wire
2023-12-01 6:55:5 am Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now Zacks
   

Please consider a small donation if you think this website provides you with relevant information